Kineta (Reverse Merger With Yumanity Therapeutics) (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 10, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $45,000,000
Company Info
- Founding Year
- 2014
- Founders
- Tony Coles, Susan Lindquist
- Company Description
- Yumanity Therapeutics is a biotechnology company that transforms drug discovery for diseases caused by protein misfolding.
- Market
- Neurodegenerative diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- Alexandria Real Estate Equities, Biogen Idec, Dolby Family Ventures, Fidelity Management & Research Company, Redmile Group, Sanofi-Genzyme BioVentures